Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332

被引:21
作者
Andersson, C
Vasconcelos, NM
Sievertzon, M
Haddad, D
Liljeqvist, S
Berglund, P
Liljeström, P
Ahlborg, N
Ståhl, S
Berzins, K [1 ]
机构
[1] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden
[2] Royal Inst Technol, Dept Biotechnol, SE-10044 Stockholm, Sweden
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden
[4] Swedish Inst Infect Dis Control, Dept Vaccine Res, SE-17182 Solna, Sweden
关键词
D O I
10.1046/j.1365-3083.2001.00951.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Development of nucleic acid-based vaccines against parasitic diseases shows great promise, although certain concerns about safety aspects of conventional DNA vaccines have been raised. This study presents a comparison of antibody responses induced in mice by DNA and RNA-based immunization with vectors encoding a part of the P. falciparum antigen Pf332. Two types of plasmids were used, one conventional DNA plasmid containing a cytomegalovirus promoter and one suicidal DNA plasmid encoding the Semliki Forest virus (SFV) replicase. RNA, encoding the SFV replicase and the relevant antigen, was delivered either as naked RNA or packaged in SFV suicide particles. In general, the antibody responses induced by the DNA plasmids were low and peaking after three injections, the conventional plasmid giving the highest responses. Also the RNA delivered in SFV particles consistently induced antibody responses, although comparatively low. Analyses of the ratio of immunoglobulin (Ig)G1/IgG2a subclasses in the responses indicated that all plasmids resulted in a bias for a Th2-type of response, while the SFV-particles elicited a Th1 type of response. Importantly, all these immunogens induced an immunological memory, which could be efficiently activated by a booster injection with the corresponding protein, with unchanged patterns of IgG subclasses.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 43 条
[1]   Plasmodium falciparum: Differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA [J].
Ahlborg, N ;
Iqbal, J ;
Bjork, L ;
Stahl, S ;
Perlmann, P ;
Berzins, K .
EXPERIMENTAL PARASITOLOGY, 1996, 82 (02) :155-163
[2]   IMMUNOGENS CONTAINING SEQUENCES FROM ANTIGEN PF332 INDUCE PLASMODIUM FALCIPARUM-REACTIVE ANTIBODIES WHICH INHIBIT PARASITE GROWTH BUT NOT CYTOADHERENCE [J].
AHLBORG, N ;
IQBAL, J ;
HANSSON, M ;
UHLEN, M ;
MATTEI, D ;
PERLMANN, P ;
STAHL, S ;
BERZINS, K .
PARASITE IMMUNOLOGY, 1995, 17 (07) :341-352
[3]   EPITOPE SPECIFICITY AND CAPACITY TO INHIBIT PARASITE GROWTH IN-VITRO OF HUMAN-ANTIBODIES TO REPEAT SEQUENCES OF THE PLASMODIUM-FALCIPARUM ANTIGEN-AG332 [J].
AHLBORG, N ;
FLYG, BW ;
IQBAL, J ;
PERLMANN, P ;
BERZINS, K .
PARASITE IMMUNOLOGY, 1993, 15 (07) :391-400
[4]   Predominance of H-2(d)- and H-2(k)-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332 [J].
Ahlborg, N ;
Sterky, F ;
Haddad, D ;
Perlmann, P ;
Nygren, PA ;
Andersson, R ;
Berzins, K .
MOLECULAR IMMUNOLOGY, 1997, 34 (05) :379-389
[5]   Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen [J].
Andersson, C ;
Liljeström, P ;
Ståhl, S ;
Power, UF .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2000, 29 (04) :247-253
[6]  
ANDERSSON C, 2001, IN PRESS BIOTECHNOL
[7]  
[Anonymous], MALARIA MOL CLIN ASP
[8]   Overcoming codon bias:: A method for high-level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli [J].
Baca, AM ;
Hol, WGJ .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2000, 30 (02) :113-118
[9]   Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum [J].
Belperron, AA ;
Feltquate, D ;
Fox, BA ;
Horii, T ;
Bzik, DJ .
INFECTION AND IMMUNITY, 1999, 67 (10) :5163-5169
[10]   Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice [J].
Berglund, P ;
Fleeton, MN ;
Smerdou, C ;
Liljeström, P .
VACCINE, 1999, 17 (05) :497-507